Elevated acid sphingomyelinase (aSMase) levels, by degrading SM, suggest disease onset or progression of neurological disorders, including major depression, ischemic stroke, amyotrophic lateral sclerosis, multiple sclerosis, and some neurodegenerative diseases such as Alzheimer’s disease [6]. This evidence concerns the gene SMPD1 and ischemic stroke.